05 January 2022
License Agreement in Canada for Accrufer®
Shield Therapeutics plc announces that it has entered into an exclusive license agreement for Accrufer® with KYE Pharmaceuticals Inc. in Canada. For further details click here.
Shield Therapeutics plc announces that it has entered into an exclusive license agreement for Accrufer® with KYE Pharmaceuticals Inc. in Canada. For further details click here.